Title |
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
|
---|---|
Published in |
The Lancet, May 2020
|
DOI | 10.1016/s0140-6736(20)31042-4 |
Pubmed ID | |
Authors |
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, Yuk-Yung Ng, Jenny Lo, Jacky Chan, Anthony Raymond Tam, Hoi-Ping Shum, Veronica Chan, Alan Ka-Lun Wu, Kit-Man Sin, Wai-Shing Leung, Wai-Lam Law, David Christopher Lung, Simon Sin, Pauline Yeung, Cyril Chik-Yan Yip, Ricky Ruiqi Zhang, Agnes Yim-Fong Fung, Erica Yuen-Wing Yan, Kit-Hang Leung, Jonathan Daniel Ip, Allen Wing-Ho Chu, Wan-Mui Chan, Anthony Chin-Ki Ng, Rodney Lee, Kitty Fung, Alwin Yeung, Tak-Chiu Wu, Johnny Wai-Man Chan, Wing-Wah Yan, Wai-Ming Chan, Jasper Fuk-Woo Chan, Albert Kwok-Wai Lie, Owen Tak-Yin Tsang, Vincent Chi-Chung Cheng, Tak-Lun Que, Chak-Sing Lau, Kwok-Hung Chan, Kelvin Kai-Wang To, Kwok-Yung Yuen |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 176 | 14% |
United States | 158 | 12% |
Mexico | 39 | 3% |
India | 37 | 3% |
United Kingdom | 34 | 3% |
Pakistan | 19 | 1% |
France | 18 | 1% |
Canada | 16 | 1% |
Australia | 12 | <1% |
Other | 150 | 12% |
Unknown | 639 | 49% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1082 | 83% |
Scientists | 102 | 8% |
Practitioners (doctors, other healthcare professionals) | 93 | 7% |
Science communicators (journalists, bloggers, editors) | 21 | 2% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1604 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 198 | 12% |
Researcher | 184 | 11% |
Student > Master | 145 | 9% |
Student > Ph. D. Student | 128 | 8% |
Other | 117 | 7% |
Other | 328 | 20% |
Unknown | 504 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 383 | 24% |
Biochemistry, Genetics and Molecular Biology | 137 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 132 | 8% |
Immunology and Microbiology | 60 | 4% |
Agricultural and Biological Sciences | 53 | 3% |
Other | 252 | 16% |
Unknown | 587 | 37% |